Dexamethasone palmitate: A promising intratympanic treatment option for severe sudden hearing loss.

Dexamethasone palmitate (DXP) is a lipophilic, esterified corticosteroid with sustained-release properties that may provide advantages over conventional water-soluble dexamethasone in intratympanic therapy for sudden sensorineural hearing loss (SSNHL…

Preview only. Read the full abstract at the source